Gurtner Explains How TauTona Is Rethinking Medtech Innovation Geoff Gurtner, MD, managing partner of TauTona Group, is trying to look differently at how Medtech is created, funded and sold.
Geoffrey C. Gurtner, MD
Co-Founder & Managing Partner
Geoff is the co-founder of TauTona Group, where he provides insights to new opportunities in clinical situations. As a practicing surgeon, he has first-hand knowledge of inefficiencies in the healthcare process. With Geoff’s medical perspective, TauTona is uniquely positioned to develop products addressing both obvious and non-obvious clinical needs.
Geoff is the Johnson and Johnson Professor of Surgery and Professor of Materials Science and Engineering at Stanford University. He currently serves as the Associate Chairman for Research in the Department of Surgery and is the Executive Director of the Stanford Wound Care Center. Geoff is a magna cum laude graduate of Dartmouth College and an AOA graduate of the University of California-San Francisco School of Medicine. He completed a general surgery residency at Massachusetts General Hospital, a plastic surgery residency at NYU School of Medicine and received advanced training in microsurgery at the University of Texas-MD Anderson Cancer Center. He is board certified in both general surgery and plastic surgery. He is the author of over 180 peer-reviewed publications in both scientific and surgical literature and editor for two major textbooks in the field: Grabb & Smith’s Plastic Surgery and Plastic Surgery. Geoff was awarded the James Barrett Brown Award (for best paper in plastic surgery) in both 2009 and 2010, and has been named “Researcher of the Year” by the American Society of Plastic Surgeons and the American Association of Plastic Surgeons. His research has led to the development of several novel biomedical technologies.
Geoff has co-founded several start-ups focused on wound healing, aesthetics and cardiovascular health, including Synvascular and Arresto Biosciences.
Meet Our Host
Geoff has been in medtech for over two decades in both operational and investment roles. He is passionate about the industry potential and sharing stories from the front lines of innovation.